Author Question: A series of cross-tabulations between an outcome variable and several possible causal variables ... (Read 61 times)

haleyc112

  • Hero Member
  • *****
  • Posts: 600
A series of cross-tabulations between an outcome variable and several possible causal variables presented in a single table on a single page is known as a(n)
 a. tabulation template.
  b. tabulation matrix.
  c. banner table.
  d. causal digest.
  e. analysis legend.

Question 2

The EDGAR Online case history showed that:
 a. it is not possible to increase the number of leads generated.
  b. a lead scoring system can increase the number of leads correctly classified.
  c. it is unlikely that the number of leads closed can be increased.
  d. sales-ready leads are not actually significantly better than non-sales-ready leads are



duy1981999

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

c

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library